Patents Assigned to ADT PHARMACEUTICALS, INC.
  • Method of selectively inhibiting Ras-mediated tumor growth in humans
    Patent number: 9931315
    Abstract: Disclosed are compounds, for example, a compound of formula I, wherein R, R0, R1-R8, n, X, Y, Y?, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition for example, cancer, mediated by the ras gene.
    Type: Grant
    Filed: February 29, 2016
    Date of Patent: April 3, 2018
    Assignee: ADT Pharmaceuticals, Inc.
    Inventors: Gary A. Piazza, Xi Chen, Adam B. Keeton, Michael R. Boyd
  • Indenyl compounds, pharmaceutical compositions, and medical uses thereof
    Patent number: 9862698
    Abstract: Disclosed are compounds, for example, compounds of formula I, wherein R, R0, R1-R8, n, X, Y, Y?, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition, for example, cancer.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: January 9, 2018
    Assignee: ADT Pharmaceuticals, Inc.
    Inventors: Gary A. Piazza, Xi Chen, Adam B. Keeton, Michael R. Boyd
  • METHOD OF TREATING OR PREVENTING RAS-MEDIATED DISEASES
    Publication number: 20160175275
    Abstract: Disclosed are compounds, for example, a compound of formula I, wherein R, R0, R1-R8, n, X, Y, Y?, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition for example, cancer, mediated by the ras gene.
    Type: Application
    Filed: February 29, 2016
    Publication date: June 23, 2016
    Applicant: ADT PHARMACEUTICALS, INC.
    Inventors: Gary A. Piazza, Xi Chen, Adam B. Keeton, Michael R. Boyd